Kong, Fangfang
Zhou, Junjun
Du, Chengrun
He, Xiayun
Kong, Lin
Hu, Chaosu
Ying, Hongmei
Article History
Received: 4 December 2017
Accepted: 7 November 2018
First Online: 20 November 2018
Ethics approval and consent to participate
: This study was approved by the Institutional Review Boards of Fudan University Shanghai Cancer Center, China. Written informed consent was obtained from the patients before treatment. Due to the retrospective design of the study, the local ethic committee confirmed that informed consent was not necessary from participants.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.